Literature DB >> 26703193

Topical vs Intravenous Tranexamic Acid in Primary Total Hip Arthroplasty: A Double-Blind, Randomized Controlled Trial.

Wayne T North1, Nima Mehran1, Jason J Davis1, Craig D Silverton1, Robb M Weir1, Michael W Laker1.   

Abstract

BACKGROUND: Tranexamic acid (TXA) reduces perioperative blood loss in total hip arthroplasty (THA).
METHODS: In our randomized control trial, 139 patients were enrolled and received 2 g of either topical or intravenous (IV) TXA. Preoperative and postoperative protocols were standardized.
RESULTS: Calculated blood and Hgb loss were lower in the IV group (1195.0 ± 485.9 mL, 1442.7 ± 562.7 mL; P = .006), (160.3 [g] ± 63.8, 188.4 [g] ± 68.5; P = .014). There was a trend toward significance in transfusion reduction (11% [IV] vs 18% [topical]; P = .3). Both groups effectively reduced the transfusion rate. There was significant financial incentive for the use of TXA in THA with a savings of $314 per patient.
CONCLUSIONS: IV and topical TXA are effective tools to reduce blood loss and transfusion costs in THA, and we recommend the IV form for ease of use.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cost reduction in primary hip arthroplasty; perioperative blood conservation; risk reduction in primary hip arthroplasty; total hip arthroplasty; tranexamic acid

Mesh:

Substances:

Year:  2015        PMID: 26703193     DOI: 10.1016/j.arth.2015.11.003

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  15 in total

1.  Optimal route for administering tranexamic acid in primary unilateral total hip arthroplasty: Results from a multicenter cohort study.

Authors:  Jinwei Xie; Shaoyun Zhang; Guo Chen; Hong Xu; Zongke Zhou; Fuxing Pei
Journal:  Br J Clin Pharmacol       Date:  2019-07-10       Impact factor: 4.335

2.  Incidental findings detected on preoperative CT imaging obtained for robotic-assisted joint replacements: clinical importance and the effect on the scheduled arthroplasty.

Authors:  Gary Tran; Lafi S Khalil; Allen Wrubel; Chad L Klochko; Jason J Davis; Steven B Soliman
Journal:  Skeletal Radiol       Date:  2020-11-03       Impact factor: 2.199

3.  Matched cohort study of topical tranexamic acid in cementless primary total hip replacement.

Authors:  Javier Sanz-Reig; Jesus Mas Martinez; Carmen Verdu Román; Manuel Morales Santias; Enrique Martínez Gimenez; David Bustamante Suarez de Puga
Journal:  Eur J Orthop Surg Traumatol       Date:  2018-03-29

Review 4.  Ultrasound evaluations and guided procedures of the painful joint arthroplasty.

Authors:  Steven B Soliman; Jason J Davis; Stephanie J Muh; Saifuddin T Vohra; Ashish Patel; Marnix T van Holsbeeck
Journal:  Skeletal Radiol       Date:  2022-05-28       Impact factor: 2.128

5.  Comparison of efficacy and safety of topical versus intravenous tranexamic acid in total hip arthroplasty: A meta-analysis.

Authors:  Jian Li; Zhijie Zhang; Jie Chen
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

Review 6.  Topical versus systemic tranexamic acid after total knee and hip arthroplasty: A meta-analysis of randomized controlled trials.

Authors:  Yongcai Chen; Zhuo Chen; Shuo Cui; Zhiyang Li; Zhengjiang Yuan
Journal:  Medicine (Baltimore)       Date:  2016-10       Impact factor: 1.889

7.  Intravenous versus topical tranexamic acid in primary total hip replacement: A meta-analysis.

Authors:  Pei Zhang; Yuan Liang; Pengtao Chen; Yongchao Fang; Jinshan He; Jingcheng Wang
Journal:  Medicine (Baltimore)       Date:  2016-12       Impact factor: 1.889

Review 8.  Efficacy and safety of intravenous tranexamic acid administration in patients undergoing hip fracture surgery for hemostasis: A meta-analysis.

Authors:  Pei Zhang; Jinshan He; Yongchao Fang; Pengtao Chen; Yuan Liang; Jingcheng Wang
Journal:  Medicine (Baltimore)       Date:  2017-05       Impact factor: 1.889

9.  Combined application versus topical and intravenous application of tranexamic acid following primary total hip arthroplasty: a meta-analysis.

Authors:  Pei Zhang; Yuan Liang; Pengtao Chen; Yongchao Fang; Jinshan He; Jingcheng Wang
Journal:  BMC Musculoskelet Disord       Date:  2017-02-21       Impact factor: 2.362

10.  Is topical or intravenous tranexamic acid preferred in total hip arthroplasty? A randomized, controlled, noninferiority clinical trial.

Authors:  Kai-di Zhou; Hong-Yi Wang; Yi Wang; Zhi-Hong Liu; Chuan He; Jian-Min Feng
Journal:  PLoS One       Date:  2018-10-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.